Neurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran; Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.
World Neurosurg. 2022 Jun;162:126-137.e1. doi: 10.1016/j.wneu.2022.03.076. Epub 2022 Mar 22.
In this systematic review and meta-analysis, we review the literature regarding patients with Cushing's disease (CD) with negative or inconclusive magnetic resonance imaging (MRI).
A quantitative systematic review was performed. Article selection was performed by searching MEDLINE (using PubMed), EMBASE, and Cochrane electronic bibliographic databases.
28 articles described surgical management of inconclusive MRI or MRI-negative CD. A total of 858 patients underwent surgery for their Cushing adenoma. Different types of surgery, including endoscopic endonasal transsphenoidal surgery (EETS) (190 cases) and microscopic endonasal transsphenoidal surgery (METS) (488 cases), were performed on patients with MRI-negative CD. 7 studies, which included 164 patients, did not describe any surgery. EETS and METS are conducted to achieve selective adenomectomy (231 cases), partial adenomectomy (80 cases), total adenomectomy (13 cases), hemihypophysectomy (15 cases), or enlarged adenomectomy (48 cases). Based on available data on these studies, the remission rate, persistence rate, and recurrence rate after different types of surgeries on patients with MRI-negative CD were 72.97%, 27.03%, and 12.05%, respectively. There was no statistically significant difference between EETS and METS in the subanalysis regarding recurrence rate, remission rate, and persistence rate. However, the recurrence rate in the METS group is almost 3 times higher than in the EETS group.
Surgery has a good prognosis in patients with MRI-negative CD in terms of remission, and EETS has a lower rate of disease recurrence than METS; therefore, EETS seems to be the potential recommended treatment technique, while to confirm the therapeutic method of choice, further investigations should be done.
在这项系统评价和荟萃分析中,我们回顾了关于磁共振成像(MRI)阴性或不确定的库欣病(CD)患者的文献。
进行了定量系统评价。通过搜索 MEDLINE(使用 PubMed)、EMBASE 和 Cochrane 电子书目数据库进行文章选择。
28 篇文章描述了 MRI 阴性或 MRI 不确定的 CD 患者的手术治疗。共有 858 例库欣腺瘤患者接受了手术治疗。对 MRI 阴性的 CD 患者进行了不同类型的手术,包括内镜经鼻蝶窦手术(EETS)(190 例)和显微镜经鼻蝶窦手术(METS)(488 例)。7 项研究(包括 164 例患者)未描述任何手术。EETS 和 METS 用于实现选择性腺瘤切除术(231 例)、部分腺瘤切除术(80 例)、全腺瘤切除术(13 例)、半垂体切除术(15 例)或扩大腺瘤切除术(48 例)。基于这些研究的可用数据,MRI 阴性 CD 患者接受不同类型手术后的缓解率、持续率和复发率分别为 72.97%、27.03%和 12.05%。在复发率、缓解率和持续率方面,EETS 和 METS 的亚分析没有统计学差异。然而,METS 组的复发率几乎是 EETS 组的 3 倍。
就缓解而言,手术对 MRI 阴性 CD 患者具有良好的预后,EETS 的疾病复发率低于 METS;因此,EETS 似乎是潜在的推荐治疗技术,然而,为了确定首选的治疗方法,还需要进一步的研究。